What is the appropriate workup and treatment for telogen effluvium in an adult woman presenting with diffuse hair shedding?

Telogen Effluvium: Workup and Treatment

For an adult woman with diffuse hair shedding from telogen effluvium, identify and remove the triggering factor (stress, illness, nutritional deficiency), check serum ferritin and thyroid function (TSH, T3, T4) in all cases without obvious cause, and consider topical or low-dose oral minoxidil as supportive therapy while providing reassurance that the condition is self-limited and resolves in 3-6 months once the trigger is addressed 1.

Diagnostic Approach

Clinical Presentation

Look for abrupt, rapid, generalized shedding of normal club hairs occurring 2-3 months after a triggering event such as childbirth, high fever, major surgery, or emotional stress 1. The key distinguishing feature is the temporal relationship between the trigger and hair loss onset.

Essential Laboratory Workup

• Serum ferritin levels - Iron deficiency is one of the two most common associated conditions
• Thyroid function tests (TSH, T3, T4) - Thyroid disorders frequently present without obvious clinical features
• Complete blood count and routine urinalysis 1

These labs should be checked in all cases of diffuse hair loss without a discernible cause, as iron deficiency and thyroid disorders often lack apparent clinical manifestations 1.

Diagnostic Testing Options

• Hair pull test - Should become negative with improvement
• Hair wash test - Quantifies shedding
• Trichoscopy - Can help differentiate from other causes
• Scalp biopsy - Reserved for unclear cases; shows normal histology in telogen effluvium versus miniaturization in female pattern hair loss 1, 2

Differential Diagnosis Considerations

Distinguish telogen effluvium from:

• Female pattern hair loss (FPHL): Presents with gradual diffuse thinning, central scalp involvement, widening of central part, or frontotemporal recession rather than acute shedding 1
• Chronic telogen effluvium: Excessive alarming shedding from a normal-looking scalp with plenty of hair, without obvious cause, lasting 3-10 years 1
• Diffuse alopecia areata: Different clinical pattern
• Loose anagen syndrome: Distinct entity 3

Treatment Strategy

Primary Management: Address the Trigger

The most important component is identifying and correcting the underlying cause 2. Common triggers include:

• Physiological stress (childbirth, surgery)
• Emotional stress
• Acute febrile illness
• Nutritional deficiencies (iron, ferritin, vitamin D)
• Medications
• Thyroid disorders 1, 2, 4

Supportive Pharmacotherapy

According to the most recent international consensus 5, 6:

Minoxidil is the primary treatment for telogen effluvium 6. You have two options:

Topical Minoxidil

• 2% solution twice daily (FDA-approved for women) or 5% foam once daily
• Advantages: Established safety profile, over-the-counter availability
• Disadvantages: Daily application required, may affect hairstyle, contact dermatitis risk (often from propylene glycol), requires cutaneous absorption 5

Low-Dose Oral Minoxidil (LDOM)

• Dosing range: 0.25-5 mg daily (off-label use)
• Preferred when entire scalp is involved 6
• Advantages: Ease of use, better compliance, no effect on hairstyle, bypasses limitations of cutaneous absorption 6
• Common side effects: Transient shedding with initiation, hypertrichosis 5
• Requires baseline cardiovascular evaluation and monitoring per 2025 consensus guidelines 5

The relative efficacy between topical and oral formulations appears similar - two controlled prospective trials showed no statistically significant differences in efficacy between 5% topical minoxidil 1-2 times daily versus 1 mg oral minoxidil 6.

Novel Therapies

Emerging evidence supports:

• Red LED light therapy: May accelerate cessation of hair loss and enhance regrowth in post-COVID telogen effluvium 7
• CNPDA formulation (caffeine, niacinamide, panthenol, dimethicone, acrylate polymer) 2

Patient Counseling: Critical Component

Repeated reassurance, support, and explanation are guiding principles 1. Specifically explain:

• The condition represents excessive shedding, not actual permanent hair loss
• It does not lead to baldness
• Telogen effluvium is self-limited and resolves in 3-6 months if the trigger is removed or treated 1
• Initial shedding may occur with minoxidil therapy before improvement

Common Pitfalls to Avoid

1. Failing to check ferritin and thyroid function - These are frequently abnormal without obvious clinical signs 1
2. Confusing telogen effluvium with chronic telogen effluvium or FPHL - The acute onset and temporal relationship to triggers distinguish true telogen effluvium
3. Not counseling about transient shedding when initiating minoxidil therapy 5
4. Inadequate reassurance - Anxiety about hair loss can perpetuate the condition

Prognosis

With appropriate trigger identification and removal, expect spontaneous resolution within 3-6 months 1. The condition has excellent prognosis when properly managed, significantly impacting quality of life during treatment but not causing permanent hair loss.